When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMV - IMV's DPX-Survivac study shows prolonged durable clinical responses
IMV Inc.
IMV (NASDAQ:IMV) jumps 9.4% in premarket trading after results from its Phase 2 study of DPX-Survivac immunotherapy in advanced recurrent ovarian cancer showed prolonged durable clinical responses alongside favorable tolerability.
More news on: IMV Inc., Healthcare stocks news, Stocks on the move,